Last: | $226.25 |
---|---|
Change Percent: | 0.99% |
Open: | $224.31 |
Close: | $224.04 |
High: | $226.55 |
Low: | $224.31 |
Volume: | 1,011,331 |
Last Trade Date Time: | 05/07/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$226.25 | $224.31 | $224.04 | $226.55 | $224.31 | 1,011,331 | 05-07-2024 |
$224.04 | $225.43 | $224.04 | $226.09 | $223.19 | 1,582,709 | 05-06-2024 |
$223.95 | $223.63 | $223.95 | $224.86 | $222.2 | 2,222,046 | 05-03-2024 |
$224.74 | $228.49 | $224.74 | $228.792 | $224.32 | 2,042,140 | 05-02-2024 |
$229.2 | $229.15 | $229.2 | $231.55 | $224.8 | 3,291,636 | 05-01-2024 |
$239.05 | $239.78 | $239.05 | $240.26 | $238 | 1,486,207 | 04-30-2024 |
$239.93 | $240 | $239.93 | $240.86 | $238.21 | 911,858 | 04-29-2024 |
$240.88 | $240.04 | $240.88 | $241.36 | $238.095 | 972,783 | 04-26-2024 |
$239.76 | $239.03 | $239.76 | $241.05 | $238.25 | 831,148 | 04-25-2024 |
$237.95 | $237.59 | $237.95 | $238.79 | $235.84 | 920,108 | 04-24-2024 |
$237.69 | $237.43 | $237.69 | $238.72 | $236.245 | 1,430,856 | 04-23-2024 |
$236.85 | $236 | $236.85 | $239.01 | $234.73 | 2,287,125 | 04-22-2024 |
$239.13 | $238.68 | $239.13 | $239.91 | $236.98 | 1,411,190 | 04-19-2024 |
$237.3 | $239.4 | $237.3 | $239.4 | $235.39 | 1,443,314 | 04-18-2024 |
$238.62 | $239.22 | $238.62 | $239.26 | $236.24 | 1,028,618 | 04-17-2024 |
$238.26 | $237.48 | $238.26 | $239.77 | $236.62 | 1,981,544 | 04-16-2024 |
$234.21 | $236.35 | $234.21 | $236.82 | $234.17 | 986,035 | 04-15-2024 |
$234 | $235 | $234 | $236.24 | $233.095 | 822,327 | 04-12-2024 |
$235.64 | $238.44 | $235.64 | $238.44 | $235.27 | 810,744 | 04-11-2024 |
$237.8 | $238.29 | $237.8 | $240.43 | $237.62 | 712,151 | 04-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
CoreSite Realty Corporation Company Name:
COR Stock Symbol:
NYSE Market:
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...
Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $2.09 and Adjusted Diluted EPS of $3.80 Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50 for Fiscal 2024 Cencora, Inc. (NYSE: COR) toda...
Cencora (NYSE:COR) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 13.96%. ...